Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00300755 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD)

StatusCompleted
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv15
  2. Results first posted: May 19, 2010 Primary endpoint revised · Enrollment target: estimated 65 to confirmed 60 · Start date: Apr 2006 to May 2006 · 1 morev14 Show all 5 changesShow less
    • Primary endpoint revised
    • Enrollment target: estimated 65 to confirmed 60
    • Start date: Apr 2006 to May 2006
    • Secondary endpoints: 4 to 3

    See this version in full on ClinicalTrials.gov ↗

  3. Trial status: Recruiting to Completed Study sites revised (43)v13 Show all 2 changesShow less
    • Study sites revised (43)

    See this version in full on ClinicalTrials.gov ↗

  4. Study sites revised (43)v12 Show moreShow less

    See this version in full on ClinicalTrials.gov ↗

  5. Primary and study completion dates: Apr 2008 Secondary endpoints: details revised at 4 of 4 entries · Study arms: 0 to 3 · Collaborators expanded, about 1 wordv11 Show all 4 changesShow less
    • Secondary endpoints: details revised at 4 of 4 entries
    • Study arms: 0 to 3
    • Collaborators expanded, about 1 word

    See this version in full on ClinicalTrials.gov ↗

Show 9 earlier versionsHide 9 earlier versions
  1. Study sites: 42 to 43v10
  2. Study sites: 43 to 42 Secondary endpoints revised (4)v9 Show all 2 changesShow less
    • Secondary endpoints revised (4)

    See this version in full on ClinicalTrials.gov ↗

  3. Primary endpoint revisedv8 Show moreShow less

    See this version in full on ClinicalTrials.gov ↗

  4. Secondary endpoints revised (4) Primary endpoint revisedv7 Show all 2 changesShow less
    • Primary endpoint revised

    See this version in full on ClinicalTrials.gov ↗

  5. Trial status: Not Yet Recruiting to Recruiting Study sites: 29 to 43 · Start date: Aug 2006 to Apr 2006v6 Show all 3 changesShow less
    • Study sites: 29 to 43
    • Start date: Aug 2006 to Apr 2006
  6. Re-verified, no change to tracked fieldsv5
  7. Start date: Apr 2006 to Aug 2006v4
  8. Start date: May 2006 to Apr 2006v3
  9. Start date: Apr 2006 to May 2006v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To evaluate the clinical outcomes of treatment with oral pantoprazole in children 1 through 5 years of age with endoscopically proven symptomatic GERD.
Trial Details
NCT Number NCT00300755
Lead Sponsor Wyeth is now a wholly owned subsidiary of Pfizer
Collaborators: Nycomed
Conditions Gastroesophageal Reflux
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov